Bioequivalence study with lapatinib powder for oral suspension and the original tablet formulation in cancer patients

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|4|3|203-209

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.3, 2015-03, pp. : 203-209

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Eslicarbazepine Acetate (BIA 2-093): Relative Bioavailability and Bioequivalence of 50 mg/mL Oral Suspension and 200mg and 800mg Tablet Formulations

By Fontes-Ribeiro Carlos  

Drugs in R&D, Vol. 6, Iss. 5, 2005-01 ,pp. : 253-260

Adis International

Access to resources Recommend Favorite

Bioequivalence Study of Two Formulations (Sachet and Tablet) of Cefixime after Single Oral Doses of 200mg in Healthy Male Volunteers

By Evène E.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 287-294

Adis International

Access to resources Recommend Favorite

Human Bioequivalence Study of Clarithromycin from Two Tablet Formulations after Single Oral Administration

By Niopas I.  

Clinical Drug Investigation, Vol. 21, Iss. 3, 2001-03 ,pp. : 211-217

Adis International

Access to resources Recommend Favorite

Absorption of Fentanyl from Fentanyl Buccal Tablet in Cancer Patients With or Without Oral Mucositis: A Pilot Study

By Darwish Mona  

Clinical Drug Investigation, Vol. 27, Iss. 9, 2007-01 ,pp. : 605-611

Adis International

Access to resources Recommend Favorite

Fexofenadine in pediatrics: oral tablet and suspension formulations

By Mansfield Lyndon E  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 2, 2008-02 ,pp. : 329-337

Informa Healthcare

Access to resources Recommend Favorite